Tag: JPIAMR

EU Commissioner urges countries to join JPIAMR

Anders BjersNews and press

In a speech on June 20, at the Second Ministerial Conference on Antimicrobial Resistance in The Netherlands, Vytenis Andriukaitis, the Commissioner for Health and Food Safety, reaffirmed his positive view of JPIAMR by saying: “Collaboration is an essential part of any successful research programme. So, I am particularly proud of the Joint Programming Initiative on antimicrobial resistance, which pools the national research efforts of 27 countries on 5 continents and covers the full One Health spectrum.”

Also, in his speech, Commissioner Andriukaitis urged Ministers present and their countries to join JPIAMR: ”This Initiative grows stronger with every new member, so we need more countries and more investment. The Virtual Research Institute under the Joint Programming Initiative on AMR (JPIAMR) will create a platform to increase coordination, improve visibility, and facilitate knowledge exchange and capacity development as well as the use of scientific evidence.
Ministers, join us in this work!”

JPIAMR at the Second Ministerial Conference on AMR

Anders BjersNews and press

On 19-20 June 2019, JPIAMR will participate in the Second Ministerial Conference on Antimicrobial Resistance, Accelerating Ambitions for Future Health in Noordwijk, The Netherlands. The focus of the conference will be international and multi-sectoral cooperation within the framework of the One Health approach. The program can be seen here.

JPIAMR will take part in a panel discussion in a break-out session entitled Addressing AMR to deliver the SDGs – strengthen knowledge and evidence base and hold an information stand for participants to provide information on the JPIAMR activities.

JPIAMR at Global AMR R&D Hub workshop

Anders BjersNews and press

On May 28 in Geneva, JPIAMR participated at the Global AMR R&D Hub workshop on “AMR R&D investments”. The objective was to identify and discuss opportunities for investments and new and innovative financing mechanisms for AMR R&D using a global One Health approach. It aimed at providing recommendations on how the Global AMR R&D Hub can support those activities. JPIAMR’s Laura Marin presented in one of the sessions about AMR investments and the JPIAMR AMR Research Funding Dashboard.

Download the workshop report (pdf, opens in a new window)

Download the workshop program (pdf, opens in a new window)

Nine New JPIAMR SAB members

Anna SundinNews and press

JPIAMR is pleased to welcome nine new members to the Scientific Advisory Board, SAB. The new members have diverse experience in the field of AMR, adding key knowledge and experiences to the whole SAB. Now fifthteen members strong.

The following SAB members have been appointed by the JPIAMR Management Board for the period 2019-2021:

  • Till Bachmann, UK
  • Rafael Cantón, Spain
  • Ramanan Laxminarayan, USA and India
  • Marc Lemonnier, France
  • Luísa Vieira Peixe, Portugal
  • Anngret Schneider, Germany
  • Constance Schultsz, Netherlands
  • Ed Topp, Canada
  • Jordi Vila, Spain

For individual biographies and further information, please click here.

Kick-off: ECRAID, the European Clinical Research Alliance on Infectious Diseases

Anders BjersNews and press

JPIAMR will be participating in a high-level meeting in Brussels, on January 17th 2019, on the development of ECRAID, the European Clinical Research Alliance on Infectious Diseases. ECRAID envisages a European-wide sustainable clinical research organization for infectious diseases and AMR, antimicrobial resistance. Laura Marin, JPIAMR Head of Secretariat, will participate in panels, etc.

ECRAID’s vision is to create a coordinated and permanent European clinical research infrastructure for clinical research on infectious diseases.  The focus is on two major challenges: emerging infectious diseases with epidemic or pandemic potential, caused by new or re-emerging pathogens, and AMR (antimicrobial resistance). ECRAID will be enable clinical research to be faster and easier having rapid access to and knowledge of developed clinical and laboratory sites. Trials will be conducted continuously to expand on knowledge and experience.

The organisations aim is to protect public health by generating evidence in order to improve diagnosis, prevention, and treatment.  The ECRAID mission is to facilitate and develop world class research to protect citizens of Europe against AMR (antimicrobial resistance) and infectious diseases, over the long term. Professor Herman Goossens together with epidemiologist Marc Bonten, is the project coordinators of ECRAID.

There will be panel discussions with clinical research networks, preclinical research networks, pharmaceutical and diagnostic companies,
SMEs, etc. Together with speakers such as EU Commissioner Carlos Moedas, Herman Goossens, Marc Bonten, Magda Chlebus, Executive Director, Science Policy & Regulatory Affairs, EFPIA and Jeremy Farrar, Director of the Wellcome Trust, and others. This is a closed meeting.

One Health in Focus when EU-JAMRAI Interviews JPIAMRs Laura Marin

Anders BjersNews and press

In the latest newsletter form EU-JAMRAI, Laura Marin, JPIAMRs Head of Secretariat, is interviewed. The topic is international AMR initiatives and the need of a One Health Approach.

This fits well with JPIAMR’s focus. Our Strategic Research and Innovation Agenda is based on a One Health approach, and the initiatives created by JPIAMR is often centered on global collaboration and coordinating public AMR funding.

The interview was made earlier this year at ECCMID in Spain.

Now Open: Call on AMR Diagnostics and Surveillance

Anna SundinNews and press

The Call on Diagnostics and Surveillance 2019 will fund joint transnational research projects addressing the development of diagnostic and surveillance tools, technologies and methods to detect antimicrobial resistance (AMR). Projects should address the diagnosis of AMR infections in clinical and veterinary settings, or the surveillance of AMR in humans, animals and the environment. The call promotes projects with impact in low and middle income countries (LMICs) in Asia and Africa.

AMR has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to issues such as weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.

In response to these challenges, the JPIAMR is pleased to launch this joint transnational call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods.  The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.

The total call budget is approx. 20 million Euro.

For full information about the call and the application process, please visit the call page.

The two-step application process (pre-proposal, full proposal) will have the following targeted timetable:

November 15 2018Preannouncement: Antibiotic Awareness Day 2018
December 5 2018Publication of the JPIAMR ERA-NET 2019 Call
February 18 2019 (11:00 CET)Submission deadline for pre-proposals
Mid April 2019Full proposal invitations sent to project coordinators
June 17th 2019 (11:00 CET)Submission deadline for full proposals
Last week September 2019Final funding decision taken by the CSC
Mid October 2019Final funding decision announced to applicants
End of 2019/Early 2020Start of funding

JPIAMR is Partnering on the Call to Action 2018 Conference in Ghana

Anders BjersNews and press

This is the second global conference on AMR that Wellcome Trust is co-hosting, this time together with the governments of Ghana and Thailand and the United Nations Foundation. The conference takes place in Accra on November 19-20. The Call to Action on AMR 2018, is organised in partnership with the Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance, bringing together stakeholders and pioneering projects.

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is a growing global collaborative platform, with 27 nations working to curb antibiotic resistance (AMR) with a One Health approach. In that spirit, being a partner is a natural fit.

At the conference, JPIAMR is putting focus on the recently pre-announced AMR Call on Diagnostics and Surveillance. Being included, as a partner in the program and via activities within the conference, the call is communicated together with facts about JPIAMR.

Follow the conference via #CalltoAction18 on Twitter.

Pre-announcement: Call on AMR Diagnostics and Surveillance

Anna SundinNews and press

JPIAMR is pleased to pre-announce a joint transnational research call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods.  The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.

The projected call budget is approx. 20 million Euro.

To read more about the call, please click here.

JPIAMR Highlighted in G20 Health Ministers Joint Declaration

Anders BjersNews and press

The 2018 G20 Health Ministerial Meeting in Mar del Plata, Argentina, concluded on October 4th with a joint declaration on concrete health policy proposals.

The document considers health a key aspect for sustainable development and calls for a further strengthening health systems. It also recommends concrete actions to address global issues such as antimicrobial resistance, and with commitments for “increasing the level of awareness on the prudent and responsible use and disposal of antibiotics of all healthcare providers, veterinarians, farmers and food producers and of the general public.”

In the declaration, the G20 also mentions JPIAMR together with GARDP, UNITAD, CARB-X and the TB-Alliance, welcoming the work of these leading international initiatives.

Please view the full declaration here.